BIOMARIN PHARMACEUTICAL INC 4

Robert M. Plenge received an equity compensation grant of 6,140 restricted stock units of BioMarin Pharmaceutical Inc. common stock.

On September 10, 2026, BioMarin Pharmaceutical Inc. insider Robert M. Plenge received a grant of 6,140 restricted stock units (RSUs) of common stock, reported as an acquisition under Code A, with no price applicable because the award represents equity compensation rather than an open-market transaction. Following this grant, Plenge’s direct ownership increased by 6,140 shares represented by RSUs, though the filing does not provide a trading price or the total number of shares beneficially owned after the award, limiting precise valuation.

Filing Facts

CIK

1048477

Ticker

BMRN

Form

4

Source Type

fda

Accession

0001628280-26-061940

Alert Tier

5